Postexposure subunit vaccination against chronic enteric mycobacterial infection in a natural host

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 1990-1995

  Santema, Wiebren ^a,d   Rutten, Victor ^a,b   Segers, Ruud ^c   Poot, Jacqueline ^c,d   Hensen, Selma ^c   Heesterbeek, Hans ^a   Koetsa, Ad ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c MSD Animal Health   (Netherlands)

^d CHARLES RIVER LABORATORIES   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; RECOMBINANT HEAT SHOCK PROTEIN 70; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENTEROCOLITIS; FEMALE; INFECTION CONTROL; NATURAL HOST; NONHUMAN; PARATUBERCULOSIS; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CATTLE; CATTLE DISEASES; CHRONIC DISEASE; FEMALE; HSP70 HEAT-SHOCK PROTEINS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; POST-EXPOSURE PROPHYLAXIS; PROTEIN SUBUNITS; VACCINES, SUBUNIT;

EID: 84877801148     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01121-12     Document Type: Article

References (31)

1. Autran B, Carcelain G, Combadiere B, Debre P. 2004. Therapeutic vaccines for chronic infections. Science 305:205-208.
2. Houghton M, Abrignani S. 2005. Prospects for a vaccine against the hepatitis C virus. Nature 436:961-966.
3. Brookmeyer R, Johnson E, Bollinger R. 2004. Public health vaccination policies for containing an anthrax outbreak. Nature 432:901-904.
4. Bahmanyar M, Fayaz A, Nour-Salehi S, Mohammadi M, Koprowski H. 1976. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 236:2751-2754.
5. Fine PE. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
6. Russell DG, Barry CE, III, Flynn JL. 2010. Tuberculosis: what we don't know can, and does, hurt us. Science 328:852-856.
7. Dye C, Williams BG. 2010. The population dynamics and control of tuberculosis. Science 328:856-861.
8. Wentink GH, Bongers JH, Zeeuwen AA, Jaartsveld FH. 1994. Incidence of paratuberculosis after vaccination against M. paratuberculosis in two infected dairy herds. Zentralbl. Veterinarmed. B 41:517-522.
9. Köhler H, Gyra H, Zimmer K, Dräger KG, Burkert B, Lemser B, Hausleithner D, Cubler K, Klawonn W, Hess RG. 2001. Immune reactions in cattle after immunization with a Mycobacterium paratuberculosis vaccine and implications for the diagnosis of M. paratuberculosis and M. bovis infections. J. Vet. Med. B Infect. Dis. Vet. Public Health 48:185-195.
10. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702.
11. Andersen P, Doherty TM. 2005. The success and failure of BCG- implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3:656-662.
12. Cruz A, Fraga AG, Fountain JJ, Rangel-Moreno J, Torrado E, Saraiva M, Pereira DR, Randall TD, Pedrosa J, Cooper AM, Castro AG. 2010. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J. Exp. Med. 207:1609-1616.
13. Buddle BM, Skinner MA, Wedlock DN, de Lisle GW, Vordermeier HM, Glyn Hewinson R. 2005. Cattle as a model for development of vaccines against human tuberculosis. Tuberculosis (Edinb.) 85:19-24.
14. Van Rhijn I, Godfroid J, Michel A, Rutten V. 2008. Bovine tuberculosis as a model for human tuberculosis: advantages over small animal models. Microbes Infect. 10:711-715.
15. Waters WR, Palmer MV, Thacker TC, Davis WC, Sreevatsan S, Coussens P, Meade KG, Hope JC, Estes DM. 2011. Tuberculosis immunity: opportunities from studies with cattle. Clin. Dev. Immunol. 2011:768542. doi:10.1155/2011/768542.
16. Chambers MA, Rogers F, Delahay RJ, Lesellier S, Ashford R, Dalley D, Gowtage S, Davé D, Palmer S, Brewer J, Crawshaw T, Clifton-Hadley R, Carter S, Cheeseman C, Hanks C, Murray A, Palphramand K, Pietravalle S, Smith GC, Tomlinson A, Walker NJ, Wilson GJ, Corner LA, Rushton SP, Shirley MD, Gettinby G, McDonald RA, Hewinson RG. 2011. Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers. Proc. Biol. Sci. 278:1913-1920.
17. Tompkins DM, Ramsey DS, Cross ML, Aldwell FE, de Lisle GW, Buddle BM. 2009. Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums. Proc. Biol. Sci. 276:2987-2995.
18. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, Thacker T, Gilbert SC, McShane H, Hill AV, Xing Z, Hewinson RG. 2009. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77:3364-3373.
19. Harris NB, Barletta RG. 2001. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev. 14:489-512.
20. Koets AP, Rutten VP, de Boer M, Bakker D, Valentin-Weigand P, van Eden W. 2001. Differential changes in heat shock protein-, lipoarabinomannan-, and purified protein derivative-specific immunoglobulin G1 and G2 isotype responses during bovine Mycobacterium avium subsp. paratuberculosis infection. Infect. Immun. 69:1492-1498.
21. Koets AP, Rutten VP, Hoek A, Bakker D, van Zijderveld F, Müller KE, van Eden W. 1999. Heat-shock protein-specific T-cell responses in various stages of bovine paratuberculosis. Vet. Immunol. Immunopathol. 70: 105-115.
22. Koets A, Hoek A, Langelaar M, Overdijk M, Santema W, Franken P, Eden W, Rutten V. 2006. Mycobacterial 70 kD heat-shock protein is an effective subunit vaccine against bovine paratuberculosis. Vaccine 24: 2550-2559.
23. Vary PH, Andersen PR, Green E, Hermon-Taylor J, McFadden JJ. 1990. Use of highly specific DNA probes and the polymerase chain reaction to detect Mycobacterium paratuberculosis in Johne's disease. J. Clin. Microbiol. 28:933-937.
24. Koets A, Rutten V, Hoek A, van Mil F, Müller K, Bakker D, Gruys E, van Eden W. 2002. Progressive bovine paratuberculosis is associated with local loss of CD4(+) T cells, increased frequency of gamma delta T cells, and related changes in T-cell function. Infect. Immun. 70:3856-3864.
25. Santema W, Hensen S, Rutten V, Koets A. 2009. Heat shock protein 70 subunit vaccination against bovine paratuberculosis does not interfere with current immunodiagnostic assays for bovine tuberculosis. Vaccine 27:2312-2319.
26. Ellner JJ. 2010. Immunoregulation in TB: observations and implications. Clin. Transl. Sci. 3:23-28.
27. Santema W, van Kooten P, Hoek A, Leeflang M, Overdijk M, Rutten V, Koets A. 2011. Hsp70 vaccination-induced antibodies recognize B cell epitopes in the cell wall of Mycobacterium avium subspecies paratuberculosis. Vaccine 29:1364-1373.
28. Joller N, Weber SS, Mïler AJ, Spörri R, Selchow P, Sander P, Hilbi H, Oxenius A. 2010. Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. Proc. Natl. Acad. Sci. U. S. A. 107: 20441-20446.
29. Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
30. Young D, Dye C. 2006. The development and impact of tuberculosis vaccines. Cell 124:683-687.
31. Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17:189-194.